Synthesis and characterization of thermally responsive pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules

Wujie Zhang, Kyle Gilstrap, Laying Wu, K. C. Remant Bahadur, Melissa A. Moss, Qian Wang, Xiongbin Lu, Xiaoming He

Research output: Contribution to journalArticleResearchpeer-review

99 Citations (Scopus)

Abstract

In this study, we synthesized empty core-shell structured nanocapsules of Pluronic F127 and chitosan and characterized the thermal responsiveness of the nanocapsules in size and wall-permeability. Moreover, we determined the feasibility of using the nanocapsules to encapsulate small molecules for temperature-controlled release and intracellular delivery. The nanocapsules are ∼37 nm at 37 °C and expand to ∼240 nm when cooled to 4 °C in aqueous solutions, exhibiting >200 times change in volume. Moreover, the permeability of the nanocapsule wall is high at 4 °C (when the nanocapsules are swollen), allowing free diffusion of small molecules (ethidium bromide, MW = 394.3 Da) across the wall, while at 37 °C (when the nanocapsules are swollen), the wall-permeability is so low that the small molecules can be effectively withheld in the nanocapsule for hours. As a result of their thermal responsiveness in size and wall-permeability, the nanocapsules are capable of encapsulating the small molecules for temperature-controlled release and intracellular delivery into the cytosol of both cancerous (MCF-7) and noncancerous (C3H10T1/2) mammalian cells. The cancerous cells were found to take up the nanocapsules much faster than the noncancerous cells during 45 min incubation at 37 °C. Moreover, toxicity of the nanocapsules as a delivery vehicle was found to be negligible. The Pluronic F127-chitosan nanocapsules should be very useful for encapsulating small therapeutic agents to treat diseases particularly when it is combined with cryotherapy where the process of cooling and heating between 37 °C and hypothermic temperatures is naturally done.

Original languageEnglish
Pages (from-to)6747-6759
Number of pages13
JournalACS Nano
Volume4
Issue number11
DOIs
StatePublished - 23 Nov 2010

Fingerprint

UCON 50-HB-5100
Nanocapsules
Poloxamer
Chitosan
delivery
permeability
Molecules
synthesis
encapsulating
molecules
cells
toxicity
temperature
bromides
vehicles
Cryotherapy
aqueous solutions
cooling

Keywords

  • Chitosan
  • Controlled release
  • Intracellular delivery
  • Nanocapsule
  • Pluronic F127
  • Thermal responsiveness
  • Wall-permeability

Cite this

Zhang, Wujie ; Gilstrap, Kyle ; Wu, Laying ; Remant Bahadur, K. C. ; Moss, Melissa A. ; Wang, Qian ; Lu, Xiongbin ; He, Xiaoming. / Synthesis and characterization of thermally responsive pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. In: ACS Nano. 2010 ; Vol. 4, No. 11. pp. 6747-6759.
@article{00f7a070a0c347fbbdbbdc390fbebf9e,
title = "Synthesis and characterization of thermally responsive pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules",
abstract = "In this study, we synthesized empty core-shell structured nanocapsules of Pluronic F127 and chitosan and characterized the thermal responsiveness of the nanocapsules in size and wall-permeability. Moreover, we determined the feasibility of using the nanocapsules to encapsulate small molecules for temperature-controlled release and intracellular delivery. The nanocapsules are ∼37 nm at 37 °C and expand to ∼240 nm when cooled to 4 °C in aqueous solutions, exhibiting >200 times change in volume. Moreover, the permeability of the nanocapsule wall is high at 4 °C (when the nanocapsules are swollen), allowing free diffusion of small molecules (ethidium bromide, MW = 394.3 Da) across the wall, while at 37 °C (when the nanocapsules are swollen), the wall-permeability is so low that the small molecules can be effectively withheld in the nanocapsule for hours. As a result of their thermal responsiveness in size and wall-permeability, the nanocapsules are capable of encapsulating the small molecules for temperature-controlled release and intracellular delivery into the cytosol of both cancerous (MCF-7) and noncancerous (C3H10T1/2) mammalian cells. The cancerous cells were found to take up the nanocapsules much faster than the noncancerous cells during 45 min incubation at 37 °C. Moreover, toxicity of the nanocapsules as a delivery vehicle was found to be negligible. The Pluronic F127-chitosan nanocapsules should be very useful for encapsulating small therapeutic agents to treat diseases particularly when it is combined with cryotherapy where the process of cooling and heating between 37 °C and hypothermic temperatures is naturally done.",
keywords = "Chitosan, Controlled release, Intracellular delivery, Nanocapsule, Pluronic F127, Thermal responsiveness, Wall-permeability",
author = "Wujie Zhang and Kyle Gilstrap and Laying Wu and {Remant Bahadur}, {K. C.} and Moss, {Melissa A.} and Qian Wang and Xiongbin Lu and Xiaoming He",
year = "2010",
month = "11",
day = "23",
doi = "10.1021/nn101617n",
language = "English",
volume = "4",
pages = "6747--6759",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "11",

}

Synthesis and characterization of thermally responsive pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. / Zhang, Wujie; Gilstrap, Kyle; Wu, Laying; Remant Bahadur, K. C.; Moss, Melissa A.; Wang, Qian; Lu, Xiongbin; He, Xiaoming.

In: ACS Nano, Vol. 4, No. 11, 23.11.2010, p. 6747-6759.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Synthesis and characterization of thermally responsive pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules

AU - Zhang, Wujie

AU - Gilstrap, Kyle

AU - Wu, Laying

AU - Remant Bahadur, K. C.

AU - Moss, Melissa A.

AU - Wang, Qian

AU - Lu, Xiongbin

AU - He, Xiaoming

PY - 2010/11/23

Y1 - 2010/11/23

N2 - In this study, we synthesized empty core-shell structured nanocapsules of Pluronic F127 and chitosan and characterized the thermal responsiveness of the nanocapsules in size and wall-permeability. Moreover, we determined the feasibility of using the nanocapsules to encapsulate small molecules for temperature-controlled release and intracellular delivery. The nanocapsules are ∼37 nm at 37 °C and expand to ∼240 nm when cooled to 4 °C in aqueous solutions, exhibiting >200 times change in volume. Moreover, the permeability of the nanocapsule wall is high at 4 °C (when the nanocapsules are swollen), allowing free diffusion of small molecules (ethidium bromide, MW = 394.3 Da) across the wall, while at 37 °C (when the nanocapsules are swollen), the wall-permeability is so low that the small molecules can be effectively withheld in the nanocapsule for hours. As a result of their thermal responsiveness in size and wall-permeability, the nanocapsules are capable of encapsulating the small molecules for temperature-controlled release and intracellular delivery into the cytosol of both cancerous (MCF-7) and noncancerous (C3H10T1/2) mammalian cells. The cancerous cells were found to take up the nanocapsules much faster than the noncancerous cells during 45 min incubation at 37 °C. Moreover, toxicity of the nanocapsules as a delivery vehicle was found to be negligible. The Pluronic F127-chitosan nanocapsules should be very useful for encapsulating small therapeutic agents to treat diseases particularly when it is combined with cryotherapy where the process of cooling and heating between 37 °C and hypothermic temperatures is naturally done.

AB - In this study, we synthesized empty core-shell structured nanocapsules of Pluronic F127 and chitosan and characterized the thermal responsiveness of the nanocapsules in size and wall-permeability. Moreover, we determined the feasibility of using the nanocapsules to encapsulate small molecules for temperature-controlled release and intracellular delivery. The nanocapsules are ∼37 nm at 37 °C and expand to ∼240 nm when cooled to 4 °C in aqueous solutions, exhibiting >200 times change in volume. Moreover, the permeability of the nanocapsule wall is high at 4 °C (when the nanocapsules are swollen), allowing free diffusion of small molecules (ethidium bromide, MW = 394.3 Da) across the wall, while at 37 °C (when the nanocapsules are swollen), the wall-permeability is so low that the small molecules can be effectively withheld in the nanocapsule for hours. As a result of their thermal responsiveness in size and wall-permeability, the nanocapsules are capable of encapsulating the small molecules for temperature-controlled release and intracellular delivery into the cytosol of both cancerous (MCF-7) and noncancerous (C3H10T1/2) mammalian cells. The cancerous cells were found to take up the nanocapsules much faster than the noncancerous cells during 45 min incubation at 37 °C. Moreover, toxicity of the nanocapsules as a delivery vehicle was found to be negligible. The Pluronic F127-chitosan nanocapsules should be very useful for encapsulating small therapeutic agents to treat diseases particularly when it is combined with cryotherapy where the process of cooling and heating between 37 °C and hypothermic temperatures is naturally done.

KW - Chitosan

KW - Controlled release

KW - Intracellular delivery

KW - Nanocapsule

KW - Pluronic F127

KW - Thermal responsiveness

KW - Wall-permeability

UR - http://www.scopus.com/inward/record.url?scp=78649606128&partnerID=8YFLogxK

U2 - 10.1021/nn101617n

DO - 10.1021/nn101617n

M3 - Article

VL - 4

SP - 6747

EP - 6759

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 11

ER -